Potential value of Interleukin-6 as a diagnostic biomarker in human MDD and the antidepressant effect of its receptor antagonist tocilizumab in lipopolysaccharide-challenged rats

Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

The Lancet Psychiatry · 2022 · 5.6K citations · Full text

Medicine, Health Sciences, Psychiatry +17

Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages

Florent Ginhoux, Melanie Greter, Marylène Leboeuf et al. · Science · 2010 · 5.1K citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression

Charles L. Raison, Robin E. Rutherford, Bobbi J. Woolwine et al. · JAMA Psychiatry · 2012 · 1.6K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo

Raja Atreya, Jonas Mudter, Susetta Finotto et al. · Nature Medicine · 2000 · 1.3K citations

Life Sciences, Immunology, Pathology +17

TREM-1 amplifies inflammation and is a crucial mediator of septic shock

Axel Bouchon, Fabio Facchetti, Markus A. Weigand et al. · Nature · 2001 · 1.1K citations

Veterinary Medicine, Immunology, Pathobiology +16